Novavax (Germany) Analysis

Novavax Stock Analysis Notes

About 62.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 15.18. Novavax had not issued any dividends in recent years. The entity had 1:20 split on the 10th of May 2019. Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. NOVAVAX INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1541 people. To find out more about Novavax contact Stanley Erck at 240 268 2000 or learn more at https://www.novavax.com.

Novavax Investment Alerts

Novavax Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 727.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novavax's market, we take the total number of its shares issued and multiply it by Novavax's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Novavax Profitablity

The company has Profit Margin (PM) of (0.72) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.66) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.66.

Technical Drivers

As of the 11th of December 2024, Novavax secures the Mean Deviation of 3.84, risk adjusted performance of (0.02), and Standard Deviation of 5.69. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novavax, as well as the relationship between them. Please verify Novavax mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Novavax is priced some-what accurately, providing market reflects its recent price of 8.31 per share.

Novavax Price Movement Analysis

Novavax Outstanding Bonds

Novavax Predictive Daily Indicators

Novavax Forecast Models

Novavax's time-series forecasting models are one of many Novavax's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novavax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Novavax prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novavax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novavax. By using and applying Novavax Stock analysis, traders can create a robust methodology for identifying Novavax entry and exit points for their positions.

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.